Table 3. Outcomes of 9-month angiography and 5-year clinical follow-up.

	DP-DES (n = 367)	BP-DES (n = 69)	p value
Diameter stenosis (9 m), %	18.9 ± 20.0	14.8 ± 19.9	0.120
MLD (9 m), mm	2.61 ± 0.76	2.79 ± 0.77	0.058
Late loss (9 m), mm	0.38 ± 0.62	0.26 ± 0.59	0.147
Net gain (9 m), mm	2.19 ± 0.80	2.41 ± 0.84	0.040*
Restenosis (9 m), n (%)	20 (5.4)	6 (8.7)	0.276
Cardiovascular death (5 yrs), n (%)	4 (1.1)	1 (1.4)	0.579
Non-fatal MI (5 yrs), n (%)	3 (0.8)	1 (1.4)	0.499
TVR (5 yrs), n (%)	13 (3.5)	2 (2.9)	1.000
All revascularization (5 yrs), n (%)	52 (14.2)	7 (10.1)	0.446
Stent thrombosis (5 yrs), n (%)	0 (0.0)	0 (0.0)	-
MACEs (5 yrs), n (%)	55 (15.0)	8 (11.6)	0.577

BP-DES, biodegradable polymer drug-eluting stent; DP-DES, second-generation durable polymer drug-eluting stent; MACEs, major adverse cardiac events; MI, myocardial infarction; MLD, minimal lumen diameter; TVR, target vessel revascularization.